Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-03

Clinical Trial Update: BOOM-IBD2 Pivotal Clinical Trial [NA]

View source ↗

Summary

Boomerang Medical’s BOOM-IBD2 pivotal clinical trial for ulcerative colitis and inflammatory bowel disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Boomerang Medical | Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases | NA | Status: RECRUITING